EQNCX
Price
$20.82
Change
-$0.55 (-2.57%)
Updated
Dec 18 closing price
RMFCX
Price
$54.22
Change
-$1.42 (-2.55%)
Updated
Dec 18 closing price
Ad is loading...

EQNCX vs RMFCX

Header iconEQNCX vs RMFCX Comparison
Open Charts EQNCX vs RMFCXBanner chart's image
MFS Equity Income C
Price$20.82
Change-$0.55 (-2.57%)
VolumeN/A
CapitalizationN/A
American Funds American Mutual R3
Price$54.22
Change-$1.42 (-2.55%)
VolumeN/A
CapitalizationN/A
EQNCX vs RMFCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
EQNCX vs. RMFCX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EQNCX is a Hold and RMFCX is a Buy.

FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 98.7B vs. EQNCX (595M). RMFCX pays higher dividends than EQNCX: RMFCX (1.69) vs EQNCX (0.87). EQNCX was incepted earlier than RMFCX: EQNCX (12 years) vs RMFCX (23 years). EQNCX is a more actively managed with annual turnover of: 42.00 vs. RMFCX (25.00). RMFCX has a lower initial minimum investment than EQNCX: RMFCX (250) vs EQNCX (1000). RMFCX annual gain was more profitable for investors over the last year : 12.63 vs. EQNCX (11.17). RMFCX return over 5 years is better than : 40.39 vs. EQNCX (35.21).
EQNCXRMFCXEQNCX / RMFCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence12 years23 years-
Gain YTD9.59811.42384%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets595M98.7B1%
Annual Yield % from dividends0.871.6951%
Returns for 1 year11.1712.6388%
Returns for 3 years11.7114.1683%
Returns for 5 years35.2140.3987%
Returns for 10 years73.9561.84120%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
REKR0.83N/A
-0.01%
Rekor Systems
CRBG29.99-0.44
-1.45%
Corebridge Financial
WHD61.48-1.46
-2.32%
Cactus
ABCL2.79-0.07
-2.45%
AbCellera Biologics
TRIB0.85-0.05
-5.67%
Trinity Biotech plc